This website is intended for healthcare professionals only.

Newsletter      
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Key paper evaluations

A synopsis of individual key papers that evidence improved patient outcomes and increased economic benefit with a TAVI procedure vs alternative pathways, taking into account organisational efficiency, budget considerations, patient choice and how to implement change in your organisation.

Clinical pathway:

Optimising patient discharge management after transfemoral TAVI: the multicentre European FAST-TAVI trial
Download Preview and DOWNLOAD NOW
The Vancouver 3M Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral TAVR Centers: The 3M TAVR Study
Download Preview and DOWNLOAD NOW
Vancouver TAVR Clinical Pathway. Minimalist Approach, Standardized Care, and Discharge Criteria to Reduce Length of Stay
Download Preview and DOWNLOAD NOW
Comparison of local versus general anaesthesia in patients undergoing TAVR: A meta-analysis
Download Preview and DOWNLOAD NOW
Length of stay after transfemoral TAVR: an analysis of the STS/ACC TVT
Download Preview and DOWNLOAD NOW

Landscape:

Annual Number of Candidates for TAVI Per Country: Current Estimates and Future Projections
Download Preview and DOWNLOAD NOW
Thirty-day readmission after TAVR in the US: Insights from the Nationwide Readmission Database
Download Preview and DOWNLOAD NOW
TAVR versus SAVR in intermediate-risk patients: a propensity score analysis
Download Preview and DOWNLOAD NOW

PARTNER 3:

TAVR with a Balloon-Expandable Valve in Low-Risk Patients
Download Preview and DOWNLOAD NOW
Health Status after TAVR vs SAVR in Low-risk Patients with Aortic Stenosis
Download Preview and DOWNLOAD NOW

Organisational efficiency:

SCAI/ACVP expert consensus statement on cardiovascular catheterization laboratory economics
Download Preview and DOWNLOAD NOW
Effective Operational Management in the Cardiac Catheterization Laboratory
Download Preview and DOWNLOAD NOW

This content is sponsored by Edwards Lifesciences